PUBLISHER: Polaris Market Research | PRODUCT CODE: 2030597
PUBLISHER: Polaris Market Research | PRODUCT CODE: 2030597
The global equine healthcare market size is expected to reach USD 7.80 billion by 2034, according to a new study by Polaris Market Research. The report "Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software, Others), By Indication, By Activity, By Distribution Channel, By Region - Market Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising population of horses worldwide propels the global equine healthcare market. A larger horse population results in various health issues such as diseases, injuries, and persistent conditions. As a result, there is a growing requirement for diagnostic services, treatments, and specialized care, creating an increased demand for equine healthcare professionals and facilities.
The increasing focus on research and development is driving the equine healthcare market. Research and development activities can result in the creation of new treatments, therapies, and diagnostic equipment for equine well-being. As these advancements become accessible, horse owners and veterinarians are more inclined to pursue them. This factor is leading to a higher demand for equine healthcare services.
By indication, the parasite infections segment accounted for the largest market share in 2025. It is owing to the widespread impact of parasites on horse health. Additionally, increased awareness among horse owners about the importance of regular parasite management drives segment dominance.
The e-commerce segment is expected to witness the highest growth during the forecast period. Increasing adoption of online platforms for purchasing equine health products drives the dominance.
The veterinary hospitals & clinics segment accounted for the largest market share in 2025. This is attributed to their essential role in delivering comprehensive care for horses. The extensive infrastructure, specialized staff, and advanced equipment available at these institutions boost their dominance.
North America dominated the global market share in 2025. This is fueled by the advanced veterinary infrastructure and high level of investments in equine health. Also, the significant presence of major pharmaceutical and biotechnology companies boosts the growth.
The Asia Pacific market is estimated to record a significant CAGR during the forecast period. The increasing investments in equine health infrastructure and rising awareness of animal welfare fuel the expansion. The growth is also propelled by the expanding equestrian industry in countries such as China and Australia.
Zoetis Services LLC; Arthrex Inc.; Dechra; Ceva Sante Animale; Merck & Co., Inc.; Heska Corporation; Hallmarq Veterinary Imaging; ESAOTE SPA; Vetoquinol S.A.; IDEXX Laboratories, Inc.; Elanco; Covetrus Inc.; Cargill; and Biosig Instruments Inc. are among the global players in the equine healthcare market.
Where is the Equine Healthcare Market Headed?
The expansion of rapid test kits, portable imaging technologies, digital record systems, and mobile veterinary units would improve access to equine healthcare. As diagnostic speed and convenience improve, owners and clinicians can identify disease earlier, initiate treatment faster, and monitor outcomes more effectively. These benefits are expected to support the long-term expansion of the market. The diagnostics segment is expected to witness rapid growth in the coming years. The rising demand for earlier disease detection, treatment monitoring, and outbreak management would propel the segment growth.
What Equine Healthcare Report Reveals?
What is the global market size, growth trend, and CAGR for the market through 2034?
What are the market drivers, opportunities, and restraints of the market growth?
Who are the key players, and what is their relative position in terms of competitive positioning?
How AI integration impacts the industry?
How does the demand for different products influence the market landscape?
How does the market differ in product, indication, activity, distribution channel, and geography, and which is the leading distribution channel?
What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
Polaris Market Research has segmented the equine healthcare market report on the basis of product, indication, activity, distribution channel, and region:
By Product Outlook (Revenue, USD Billion, 2021-2034)
Vaccines
Pharmaceuticals
Parasiticides
Anti-infectives
Anti-inflammatory & Analgesics
Other Pharmaceuticals
Medicinal Feed Additives
Orthobiologics
Diagnostics
Diagnostic Test Kits
Diagnostic Equipment
Software
Practice Management Software
Imaging Software
Telehealth Software
Other Software
Other
By Indication Outlook (Revenue, USD Billion, 2021-2034)
Musculoskeletal Disorders
Parasitic Infections
Equine Herpes Virus
Equine Viral Arteritis (EVA)
Equine Influenza
West Nile Virus
Tetanus
Other
By Activity Outlook (Revenue, USD Billion, 2021-2034)
Sports/Racing
Recreation
Other
By Distribution Channel Outlook (Revenue, USD Billion, 2021-2034)
Veterinary Hospitals & Clinics
E-commerce
Equestrian Facilities
Other
By Regional Outlook (Revenue, USD Billion, 2021-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America